Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Horizons Ventures

Investor type Venture Capital
Founders Debbie Chang Li Ka-shing Solina Chau


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 316
Average round size
The average size of a deal this fund participated in
Portfolio companies 183
Rounds per year 13.17
Lead investments 83
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 31
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Artificial Intelligence
  • Software
  • Biotechnology
  • Machine Learning
  • Information Technology

In 1999 was created Horizons Ventures, which is appeared as VC. The leading representative office of defined VC is situated in the Hong Kong. The company was established in Asia in Hong Kong.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Machine Learning, Hardware. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Facebook, Spotify, Airbnb. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.

This organization was formed by Debbie Chang, Li Ka-shing, Solina Chau. The overall number of key employees were 2.

The important activity for fund was in 2018. Considering the real fund results, this VC is 24 percentage points more often commits exit comparing to other organizations. This Horizons Ventures works on 18 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2019. The fund is generally included in 13-24 deals every year. The typical startup value when the investment from Horizons Ventures is more than 1 billion dollars.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Horizons Ventures, startups are often financed by Social Capital, Andreessen Horowitz, Accel. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Social Capital, Khosla Ventures. In the next rounds fund is usually obtained by Temasek Holdings, Mail.Ru Group, Khosla Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Horizons Ventures:
Typical Co-investors
Horizons Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Horizons Ventures:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$175M05 Jan 2023 Boston, Massachusetts, United States

Syzygy Plasmonics

$76M16 Nov 2022 Houston, Texas, United States


Health Care
Personal Health
15 Nov 2022 Guilford, Connecticut, United States

Juvena Therapeutics

Health Care
$41M08 Nov 2022 Palo Alto, California, United States

Nourish Ingredients

$28M19 Oct 2022 Canberra, Australian Capital Territory, Australia


Artificial Intelligence
Information Technology
Internet of Things
Machine Learning
$48M05 Oct 2022 San Diego, California, United States


Life Science
$24M24 Aug 2022 Vancouver, British Columbia, Canada

Carmot Therapeutics

Health Care
$160M26 Jul 2022 San Francisco, California, United States

Management Consulting
$36M21 Jul 2022 Stockholm, Stockholm County, Sweden
Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

– Prospection has successfully raised $45m from institutional investors in a Series B round, cornerstoned by new investor Ellerston JAADE with participation from existing shareholders Main Sequence and Horizons Ventures.
– Prospection uses real world data, powering evidence to deliver better patient outcomes. Its powerful AI algorithms follow millions of de-identified patients over time to search for patterns in their health and treatment journey. Uniquely, these algorithms can ingest multiple longitudinal patient and commercial datasets globally from varied sources such as governments, insurers, healthcare providers/institutions and health records, to produce rich and accurate insights at high speed.
– These datasets are turned into actionable, medical insights to help determine the best treatment plan for a patient, locate patients who would benefit from improved therapeutic decisions and be written into publishable evidence for scientific journals.

Owlstone Medical Raises $58M in Funding

– Owlstone Medical is a Cambridge UK-based global leader in Breath Biopsy® for applications in early disease detection and precision medicine.
– Company raised $58m in funding.
– The round was led by Horizons Ventures, which now takes a seat on Owlstone Medical’s Board, and is joined by other existing and high-profile new investors from Asia, the Middle East and the United States.
– The new investment will be used to accelerate the company’s commercialization of its Breath Biopsy tests.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Horizons Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: